2087. Comparison of Alere™ i Influenza Flu A and B 2 and Cobas® Influenza A/B Nucleic Acid Amplification Tests for Detection of Influenza A/B in Nasopharyngeal Swabs Collected from Children

Background Early diagnosis of influenza virus is critical for patient management and infection control. Both, Alere™ i Influenza A and B two assay (Alere i; Abbott Laboratories) and Cobas® Influenza A/B nucleic acid test (LIAT; Roche Molecular Systems Inc.) are rapid sample-to-answer CLIA waived molecular assays for flu detection. The aim of this study was to compare the performance of these two commercially available flu assays.